TNeuroPharma develops a therapeutic-based technology focusing on the T-cell contribution in tracking and treating neurodegenerative disease. Its technology helps to target the dysfunctional t-cells which helps in detecting Alzheimer's disease through the use of blood samples, enabling patients to detect and treat the disease at the early stage